Evidence map›Paper›PMID 31698524›Full record

ArticleTropical medicine & international health : TM & IH2020

Quantifying the HIV treatment cascade in a South African health sub-district by gender: retrospective cohort study.

Mark N Lurie, Kipruto Kirwa, Julia Callaway, Morna Cornell, Andrew Boulle, Angela M Bengtson, Mariette Smith, Natalie Leon, Christopher Colvin

Open access · greenAbstract read
In one paragraph

Article in Tropical medicine & international health : TM & IH, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Mark N LurieDepartment of Epidemiology, Brown University School of Public Health, Providence, RI, USA.
Kipruto KirwaDepartment of Environmental Health, Tufts University, Medford, OR, USA.
Julia CallawayDepartment of Epidemiology, Brown University School of Public Health, Providence, RI, USA.
Morna CornellDepartment of Health, Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.
Andrew BoulleDepartment of Health, Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.
Angela M BengtsonDepartment of Epidemiology, Brown University School of Public Health, Providence, RI, USA.
Mariette SmithDepartment of Health, Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.
Natalie LeonHealth Systems Research Unit, South African Medical Research Council, Cape Town, South Africa.
Christopher ColvinDivision of Social and Behavioural Sciences, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Brown University · USUniversity of Cape Town · ZAWellcome Centre for Infectious Diseases Research in Africa · ZASouth African Medical Research Council · ZATufts University · US

Funding

Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
Using Information to Align Services and Link and Retain Men in the HIV CascadeR01MH106600 · NIMH · UNIVERSITY OF CAPE TOWN · PI COLVIN, CHRISTOPHER JAMES, LURIE, MARK NATHAN · 2015 to 2019
$2.1M
Partnerships for the Next Generation of HIV Social Science in South AfricaR24HD077976 · NICHD · BROWN UNIVERSITY · PI COLVIN, CHRISTOPHER JAMES, LURIE, MARK NATHAN · 2013 to 2017
$1.9M
An Implementation Science Approach to Monitoring Engagement in HIV CareR00MH112413 · NIMH · BROWN UNIVERSITY · PI BENGTSON, ANGELA · 2019 to 2021
$747k
NIAID NIH HHS U01 AI069924NICHD NIH HHS R24 HD077976NIMH NIH HHS R00 MH112413NIMH NIH HHS R01 MH106600US National Institute of Child Health and Human Development 1R24HD077976
6 · The paper itself

Abstract

objectivesTo quantify the HIV care cascade in a Cape Town sub-district to understand rates of linkage to and engagement in HIV care.

methodsWe used routinely collected data to reconstruct the treatment cascade for 8382 infected individuals who tested HIV + in 2012/2013. We obtained data on patient gender, year of initial HIV-positive test, age at testing and initial CD4 cell count and defined five stages of the HIV care cascade. We quantified attrition across cascade stages.

resultsTwo-thirds of the sample (5646) were women. Men were older at time of first testing (36.5 vs. 31.3 years) and had more advanced HIV disease at diagnosis (298 vs. 404 CD4 cells/µL for women). The median duration of follow-up was 818 days. Among women, 90.5% attended an initial HIV care visit, 54.6% became eligible for antiretroviral therapy under local guidelines during follow-up, 49.3% initiated ART and 45.6% achieved a therapeutic response. Among men, 88.0% attended an initial HIV care visit, 67.4% became ART eligible during follow-up, 48.0% initiated ART and 42.4% achieved a therapeutic response. Approximately 3% of women and 5% of men died during follow-up.

conclusionsWe were able to reconstruct the HIV treatment cascade using routinely collected data. In this setting, rates of engagement in care differ by gender in key stages of the cascade, with men faring worse than women at each cascade point. This highlights the need for interventions aimed at encouraging earlier testing, linkage, ART initiation and retention among men.

Indexed as

AdolescentAdultAnti-HIV AgentsCD4 Lymphocyte CountFemaleHIV InfectionsHumansMaleMiddle AgedRetrospective StudiesSex FactorsSouth AfricaAnti-HIV AgentsAfrique du Sudcascade de traitement du VIHdifférences entre les sexesgender differencesHIV treatment cascadelien avec les soinslinkage to careSouth Africa

Identifiers

PMID31698524
PMCPMC7007356
OpenAlexW2986017343

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.